CV Lattes
Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas (FCF) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Bachelor of Molecular Sciences by University of São Paulo (2011-2015) Pharmacist-Biochemist by University of São Paulo. From 2013 to 2016, conducted a research project at IQUSP Biocolloids Laboratory, earning experience in the fields of synthesis and characterization of antimicrobial nanoparticles and also microbiology. The unfolding of the work led to experiences in antimicrobial film formation. Currently is a PhD student in the area of Pharmaceutical Supplies of the Drug and Medicines program from the Faculty of Pharmacy and Biochemistry of the University of São Paulo. The current work aims to synthesize dendrimers and dendrons targeted by heparin derivatives to Plasmodium infected erythrocytes and carrying mefloquine and/or artesunate (drugs currently used for malaria treatment), utilizing latentiation principles. Results could led to an increase in therapeutic efficacy of Malaria treatment and aid the deterrent of Plasmodium drug resistance emergence. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Malaria is a potentially fatal disease caused by protozoa of the Plasmodium genus and it affects human erythrocytes. In several regions of the world, reports of the emergence of parasites resistant to the main drugs in use have been made, leading to a rise in disease mortality rate. Artemisinin Combination Therapies (ACTs) are strongly recommended by the World Health Organization for the …
| 1 / 1 | Completed scholarships in Brazil |
| Associated processes | |